oppn parties Lax Regulation Responsible For 'Killer' Syrups?

News Snippets

  • SP drops two candidates owing allegiance to Azam Khan from Rampur and Moradabad
  • In Assam, a controversy erupted after a picture of UPPL leader Benjamin Basumatary, lying on a stack of Rs 500 notes circulated on social media. UPPL is an ally of the BJP
  • AAP's Jalandhar-West MP Sushil Kumar Rinku joins the BJP. He was the only AAP Lok Sabha MP
  • Supreme Court dismisses Centre's plea to review its 2023 verdict in the PMLA case
  • Close save for passengers as they remain unhurt after the wings of two planes graze at Kolkata airport. Pilots derostered and inquiry ordered by DGCA
  • Bengal BJP leader Dilip Ghosh gets notice from the EC as well as the BJP for making ugly remarks about Mamata Banerjee's parentage
  • Sadanand Vasanth Date, who faught terrorists in the 26/11 attack and was awarded the Preisent's Police medal, has been appointed the head of the NIA
  • Centre will borrow Rs 7.5L cr in the first six months of FY25, nearly 50% of the target for the full year
  • 25 stocks, including SBI, will see same day trade settlements from today in the world's fastest settlement mode in both BSE and NSE
  • Stocks recover smartly on Wednesday: Sensex rises 526 points to 72996 and Nifty 118 points to 22123
  • Tennis: Rohan Bopanna-Matthew Ebden reached the semifinals of the Miami Open
  • IPL: records tumble as SRH beat MI in a high-scoring match. SRH score 277/3 with 18 sixes and Mumbai score 246 with 20 sixes to fall short by 31 runs. Atotal of 38 sixes, highest in an IPL match were hit and both teams combined to score 523 runs, the highest aggregate in an IPL match
  • Amul will launch fresh milk in the US
  • IPL: RCB beat Punjab by 4 wickets as Kohli and Karthik shine with the bat
  • India strongly objected to German foreign office remarks over the arrest of delhi CM Arvind Kejriwal, called it "biased assumptions"
Delhi Lt Governor Vinai Kumar Saxena says government cannot be run from jail, hints at President's Rule in the capital ////// In a dangerous incident, the wings of two planes grazed while taxiing on the runway at Kolkata airport, all passengers were safe but DGCA ordered an inquiry and the pilots were derostered
oppn parties
Lax Regulation Responsible For 'Killer' Syrups?

By Linus Garg
First publised on 2022-10-07 14:10:59

About the Author

Sunil Garodia Linus tackles things head-on. He takes sides in his analysis and it fits excellently with our editorial policy. No 'maybe's' and 'allegedly' for him, only things in black and white.

A report by Ayushman Kumar in moneycontrol.com informs how Maiden Pharmaceuticals, the Haryana-based drug manufacturer now in the eye of a storm for selling substandard (contaminated) paediatric cough syrups to Gambia which allegedly resulted in the death of 66 children in that country and forced WHO to issue a global alert, has a past history of being reported for selling substandard products. The report highlights the fact that Vietnam had blacklisted the firm for that reason and Indian states like Kerala, Gujarat and Bihar had, at different times, either flagged the firm for supplying poor quality drugs or blacklisted it.

Yet, Maiden Pharmaceuticals has been doing roaring business and had also got the permission from Indian drug regulators to manufacture and export the four cough syrups now under the scanner. WHO has reported that preliminary tests have confirmed that the syrups were found to contain excessive levels of diethylene glycol and ethylene glycol, much beyond the permissible level. The two chemicals are mainly used as solvents in industries and are not fit for human consumption. They can damage the kidneys, especially in children and cause fatalities. 

It is indeed surprising that a company that has regularly been reported for supplying substandard drugs was allowed to manufacture the syrups and export them. The company could have used the two substances in the syrups as they are much cheaper than glycerol or glycerine which is a component of most cough syrups.  Infact, such adulteration is common and WHO mandates a compulsory DEG test before these drugs are exported. It is clear that such a test was either not performed or not done properly in India, at least in the batch that is under the scanner. The company has denied using excessive diethylene glycol and ethylene glycol and has alleged that the syrups were adulterated elsewhere. Meanwhile, state drug regulator in Haryana has collected the samples of the four syrups and sent them for analysis in the Central Drug Laboratory in Kolkata.

The incident once again shows that drug regulation in India is lax. Monitoring and inspection of manufacturing processes of drug manufacturers is not done on regular basis. In fact, some manufacturers escape scrutiny for years. Corruption is rampant. India needs to first update its archaic drug laws. Then it needs to implement a stringent good manufacturing practises (GMP) framework. It needs to fund its drug regulator well to ensure that it has trained staff in good numbers to conduct periodic checks on manufacturing facilities of pharma companies, especially of small units who are more likely to indulge in adulteration. Just making cheap generic drugs in abundance and being the largest supplier of such drugs worldwide is not enough. If India does not ensure (through strict regulation and continuous monitoring) that its drug manufacturers adhere to GMP and supply drugs that meet international standards, it will not be long before export orders will dry up.